Page last updated: 2024-08-24

halofuginone and Anoxemia

halofuginone has been researched along with Anoxemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Babicheva, A; Balistrieri, F; Carr, SG; Chen, J; Izadi, A; Jain, PP; Lai, N; Makino, A; Rahimi, S; Rodriguez, M; Shyy, JY; Simonson, T; Song, S; Thistlethwaite, PA; Valdez-Jasso, D; Wang, J; Xiong, M; Yuan, JX; Zhao, T; Zheng, Q1
Bian, ZX; Du, J; Lin, SH; Liu, J; Mu, HX; Wang, D; Wang, HS; Xiao, HT; Yang, D; Zhao, L1

Other Studies

2 other study(ies) available for halofuginone and Anoxemia

ArticleYear
Halofuginone, a promising drug for treatment of pulmonary hypertension.
    British journal of pharmacology, 2021, Volume: 178, Issue:17

    Topics: Animals; Calcium; Hypertension, Pulmonary; Hypoxia; Mice; Myocytes, Smooth Muscle; Pharmaceutical Preparations; Phosphatidylinositol 3-Kinases; Piperidines; Pulmonary Artery; Quinazolinones

2021
Halofuginone reduces the inflammatory responses of DSS-induced colitis through metabolic reprogramming.
    Molecular bioSystems, 2016, 06-21, Volume: 12, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Body Weight; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Energy Metabolism; Enzyme Activation; Fatty Acids; Gene Expression; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Liver; Male; Metabolic Networks and Pathways; Mice; Models, Biological; Oxidation-Reduction; Peroxidase; Phenotype; Piperidines; Quinazolinones; RNA, Messenger; Spleen

2016